Lista de obras - Paul Grootendorst - Dominio Público Uruguay

A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.

artículo científico publicado en 2007

A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia

artículo científico publicado en 2006

An empirical analysis of milk addiction.

artículo científico publicado en 2004

Becoming the best mom that I can: women's experiences of managing depression during pregnancy--a qualitative study

artículo científico publicado en 2007

Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.

artículo científico publicado en 2011

Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study

article

Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency Departments.

artículo científico publicado en 2015

Does it matter whom and how you ask? inter- and intra-rater agreement in the Ontario Health Survey.

artículo científico publicado en 1997

Economic evaluation of vaccines in Canada: A systematic review

artículo científico publicado en 2016

Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey

artículo científico publicado en 2011

Effect of the Low Risk Ankle Rule on the frequency of radiography in children with ankle injuries.

artículo científico publicado en 2013

Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.

artículo científico publicado en 2004

Equity in dental care among Canadian households ⬇️

artículo científico publicado el 16 de abril de 2011

Estimating the clinical cost of drug development for orphan versus non-orphan drugs

scientific article published on 10 January 2019

Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator ⬇️

artículo científico publicado el 1 de julio de 1997

Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis.

artículo científico publicado en 2011

How Effective Is the Medicare Part D Drug Plan?

artículo científico publicado en 2015

How should we support pharmaceutical innovation?

artículo científico publicado en 2009

Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis.

artículo científico publicado en 2006

Impact of depression and recreational drug use on emergency department encounters and hospital admissions among people living with HIV in Ontario: A secondary analysis using the OHTN cohort study

artículo científico publicado en 2018

Intellectual Property Protection and Drug Plan Coverage: Evidence From Ontario

scientific article published on 24 July 2018

Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature

artículo científico publicado en 2009

Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.

artículo científico publicado en 2015

Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapy

artículo científico publicado en 2000

The case for an essential medicines list for Canada

artículo científico publicado en 2016

The cost of drug development: A systematic review ⬇️

artículo científico publicado el 21 de enero de 2011

The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.

artículo científico publicado en 2002

The impact of drug vintage on patient survival: a patient-level analysis using Quebec's provincial health plan data

artículo científico publicado en 2009

The opportunity cost of capital: development of new pharmaceuticals

artículo científico publicado en 2015

Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip

artículo científico publicado en 2008

Lista de obras de Paul Grootendorst

A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study.

A re-examination of the impact of reference pricing on anti-hypertensive drug plan expenditures in British Columbia

An empirical analysis of milk addiction.

Becoming the best mom that I can: women's experiences of managing depression during pregnancy--a qualitative study

Canada's laws on pharmaceutical intellectual property: the case for fundamental reform.

Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study

Cost Consequence Analysis of Implementing the Low Risk Ankle Rule in Emergency Departments.

Does it matter whom and how you ask? inter- and intra-rater agreement in the Ontario Health Survey.

Economic evaluation of vaccines in Canada: A systematic review

Economic instruments for obesity prevention: results of a scoping review and modified Delphi survey

Effect of the Low Risk Ankle Rule on the frequency of radiography in children with ankle injuries.

Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence.

Equity in dental care among Canadian households ⬇️

Estimating the clinical cost of drug development for orphan versus non-orphan drugs

Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator ⬇️

Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis.

How Effective Is the Medicare Part D Drug Plan?

How should we support pharmaceutical innovation?

Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis.

Impact of depression and recreational drug use on emergency department encounters and hospital admissions among people living with HIV in Ontario: A secondary analysis using the OHTN cohort study

Intellectual Property Protection and Drug Plan Coverage: Evidence From Ontario

Life-expectancy gains from pharmaceutical drugs: a critical appraisal of the literature

Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.

Proportion of osteoporotic post-menopausal women at increased risk for upper GI adverse events associated with bisphosphonate therapy

The case for an essential medicines list for Canada

The cost of drug development: A systematic review ⬇️

The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada.

The impact of drug vintage on patient survival: a patient-level analysis using Quebec's provincial health plan data

The opportunity cost of capital: development of new pharmaceuticals

Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip